DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

KalVista Pharmaceuticals Q3 EPS $(0.52) Down From $(0.23) YoY, Sales $1.577M Down From $3.89M YoY

KalVista Pharmaceuticals (NASDAQ:KALV) reported quarterly losses of $(0.52) per share. This is a 126.09 percent decrease over losses of $(0.23) per share from the same period last year. The company reported $1.577

Benzinga · 03/10/2020 11:36

KalVista Pharmaceuticals (NASDAQ:KALV) reported quarterly losses of $(0.52) per share. This is a 126.09 percent decrease over losses of $(0.23) per share from the same period last year. The company reported $1.577 million in sales this quarter. This is a 59.46 percent decrease over sales of $3.89 million the same period last year.